Shi S - Search Results

1

A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.

Shi S, Ye S, Wu X, Xu M, Zhuo R, Liao Q, Xi Y. Shi S, et al. Yonsei Med J. 2019 Nov;60(11):1013-1020. doi: 10.3349/ymj.2019.60.11.1013. Yonsei Med J. 2019. PMID: 31637882 Free PMC article.

2

CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.

Shi S, Ye S, Mao J, Ru Y, Lu Y, Wu X, Xu M, Zhu T, Wang Y, Chen Y, Tang X, Xi Y. Shi S, et al. Autoimmunity. 2020 Jun;53(4):210-217. doi: 10.1080/08916934.2020.1735371. Epub 2020 Mar 4. Autoimmunity. 2020. PMID: 32129682 Free article.

3

Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.

Shi S, Xu M, Xi Y. Shi S, et al. Aging (Albany NY). 2020 Nov 24;12(23):23917-23930. doi: 10.18632/aging.104062. Epub 2020 Nov 24. Aging (Albany NY). 2020. PMID: 33237038 Free PMC article.

4

LncRNAs GACAT3 and LINC00152 regulate each other through miR-103 and are associated with clinicopathological characteristics in colorectal cancer.

Ye S, Lu Y, Ru Y, Wu X, Zhao M, Chen J, Xu M, Huang Q, Wang Y, Shi S, Bu S, Xi Y. Ye S, et al. Among authors: shi s. J Clin Lab Anal. 2020 Sep;34(9):e23378. doi: 10.1002/jcla.23378. Epub 2020 May 27. J Clin Lab Anal. 2020. PMID: 32462718 Free PMC article.

5

Cytoglobin promotes sensitivity to ferroptosis by regulating p53-YAP1 axis in colon cancer cells.

Ye S, Xu M, Zhu T, Chen J, Shi S, Jiang H, Zheng Q, Liao Q, Ding X, Xi Y. Ye S, et al. Among authors: shi s. J Cell Mol Med. 2021 Apr;25(7):3300-3311. doi: 10.1111/jcmm.16400. Epub 2021 Feb 21. J Cell Mol Med. 2021. PMID: 33611811 Free PMC article.

6

Characterization of the immune cell infiltration landscape in bladder cancer to aid immunotherapy.

Shi S, Ma T, Xi Y. Shi S, et al. Arch Biochem Biophys. 2021 Sep 15;708:108950. doi: 10.1016/j.abb.2021.108950. Epub 2021 Jun 9. Arch Biochem Biophys. 2021. PMID: 34118215

7

Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma.

Xu M, Ma T, Shi S, Xing J, Xi Y. Xu M, et al. Among authors: shi s. Life (Basel). 2021 Nov 28;11(12):1312. doi: 10.3390/life11121312. Life (Basel). 2021. PMID: 34947843 Free PMC article.

8

A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.

Shi S, Ma T, Xi Y. Shi S, et al. Front Genet. 2020 Dec 17;11:598743. doi: 10.3389/fgene.2020.598743. eCollection 2020. Front Genet. 2020. PMID: 33391349 Free PMC article.

9

A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets.

Ma T, Shi S, Jiang H, Chen X, Xu D, Ding X, Zhang H, Xi Y. Ma T, et al. Among authors: shi s. Arch Biochem Biophys. 2021 Oct 30;711:109016. doi: 10.1016/j.abb.2021.109016. Epub 2021 Aug 17. Arch Biochem Biophys. 2021. PMID: 34411579

10

The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome.

Hu H, Chen C, Shi S, Li B, Duan S. Hu H, et al. Among authors: shi s. Autoimmunity. 2019 Aug-Sep;52(5-6):192-198. doi: 10.1080/08916934.2019.1657846. Epub 2019 Sep 2. Autoimmunity. 2019. PMID: 31476899 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,712 results

Search Page

Filters